A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5554-5554
Keyword(s):
Phase Ii
◽